A new taxonomy for describing and defining adherence to medications

British Journal of Clinical Pharmacology - Tập 73 Số 5 - Trang 691-705 - 2012
Bernard Vrijens1, Sabina De Geest2,3, Dyfrig Hughes4, Przemysław Kardas5, Jenny Demonceau6, Todd M. Ruppar2,7, Fabienne Dobbels2, Emily Holmes4, Val Morrison4, Paweł Lewek5, Michał Matyjaszczyk5, Comfort Mshelia8, Wendy Clyne8, Jeffrey K Aronson9, John Urquhart10
1Department of Biostatistics and Medical Informatics, University of Liège, Liège, Belgium
2Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Leuven, Belgium
3Institute of Nursing Science, Faculty of Medicine, University of Basel, Basel, Switzerland
4Bangor University Bangor Wales UK
5Medical University of Lodz, Lodz, Poland
6AARDEX Group Ltd, Sion, Switzerland
7Sinclair School of Nursing, University of Missouri, Columbia, Missouri, USA
8NPC Plus, Keele University, Keele, UK
9Department of Primary Health Care, University of Oxford, Oxford, UK
10Department of Bioengineering & Therapeutic Sciences, UCSF, San Francisco, California, USA

Tóm tắt

Interest in patient adherence has increased in recent years, with a growing literature that shows the pervasiveness of poor adherence to appropriately prescribed medications. However, four decades of adherence research has not resulted in uniformity in the terminology used to describe deviations from prescribed therapies. The aim of this review was to propose a new taxonomy, in which adherence to medications is conceptualized, based on behavioural and pharmacological science, and which will support quantifiable parameters. A systematic literature review was performed using MEDLINE, EMBASE, CINAHL, the Cochrane Library and PsycINFO from database inception to 1 April 2009. The objective was to identify the different conceptual approaches to adherence research. Definitions were analyzed according to time and methodological perspectives. A taxonomic approach was subsequently derived, evaluated and discussed with international experts. More than 10 different terms describing medication‐taking behaviour were identified through the literature review, often with differing meanings. The conceptual foundation for a new, transparent taxonomy relies on three elements, which make a clear distinction between processes that describe actions through established routines (‘Adherence to medications’, ‘Management of adherence’) and the discipline that studies those processes (‘Adherence‐related sciences’). ‘Adherence to medications’ is the process by which patients take their medication as prescribed, further divided into three quantifiable phases: ‘Initiation’, ‘Implementation’ and ‘Discontinuation’. In response to the proliferation of ambiguous or unquantifiable terms in the literature on medication adherence, this research has resulted in a new conceptual foundation for a transparent taxonomy. The terms and definitions are focused on promoting consistency and quantification in terminology and methods to aid in the conduct, analysis and interpretation of scientific studies of medication adherence.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra050100

10.1016/0002-9149(93)90014-4

World Health Organization, 2003, Adherence to Long‐Term Therapies: Evidence for Action

10.3322/caac.20004

10.1016/j.cnur.2007.10.006

10.1378/chest.130.1_suppl.65S

10.1016/j.berh.2005.11.002

10.1016/j.ijcard.2007.10.011

Loghman‐Adham M, 2003, Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation, Am J Manag Care, 9, 155

10.1016/j.survophthal.2008.08.002

10.1097/01.icu.0000156139.05323.26

10.1111/j.1742-1241.2007.01630.x

10.1093/jac/dki066

10.3821/1913-701X(2007)140[254:MAIPI]2.0.CO;2

10.1093/ajhp/60.7.657

10.1001/archopht.1987.01060030029009

10.1111/j.1440-172X.2008.01722.x

10.1001/archopht.1988.01060130492013

10.1001/archopht.1987.01060030028008

10.1002/pds.1230

10.1111/j.1365-2648.2008.04745.x

10.1054/cein.2000.0110

10.1111/j.1471-6712.2005.00341.x

10.1161/01.HYP.11.3_Pt_2.II56

Gold DT, 2006, Medication adherence: a challenge for patients with postmenopausal osteoporosis and other chronic illnesses, J Manag Care Pharm, 12, S20

10.1111/j.1464-5491.2005.01783.x

10.1080/09546630600688515

Karoly P, 1993, Developmental Aspects of Health Compliance Behavior, 11

10.1136/thorax.57.5.459

10.1007/BF02850081

10.1159/000212579

La Greca A, 1995, Handbook of Pediatric Psychology, 55

10.1046/j.1365-2702.2000.00418.x

Linden M, 1981, Definition of compliance, Int J Clin Pharmacol Ther Toxicol, 19, 86

10.12968/bjon.2008.17.2.28140

10.1093/schbul/sbj075

10.1136/bjo.2007.118117

NICE clinical guidelines. Available athttp://www.nice.org.uk/Guidance/CG76#documents(last accessed 13 February 2009).

10.1046/j.1440-1754.2003.00081.x

Tsoneva J, 2004, Understanding patients' beliefs and goals in medicine‐taking, Prof Nurse, 19, 466

10.2165/00002512-200421120-00004

Johnson SB, 2002, Handbook of Clinical Health Psychology, Vol 2. Disorders of Behavior and Health, 329

Katz Y, 2007, Non‐adherence, non‐compliance or non‐concordance in asthma: patients not following the medical regimen, Isr Med Assoc J, 9, 389

10.1111/j.1744-618X.1993.tb00096.x

10.3109/01612849109040517

10.1111/j.1365-2125.2007.02971_2.x

10.1136/qhc.11.1.81

10.1111/j.1365-2125.2007.02971_1.x

10.1111/j.1365-2125.2008.03241.x

Haynes RB, 2002, Interventions for helping patients to follow prescriptions for medications, Cochrane Database Syst Rev, 10.1002/14651858.CD000011

Haynes RB, 2008, Interventions for enhancing medication adherence, Cochrane Database Syst Rev

HorneR WeinmanJ BarberN ElliottR MorganM.Concordance adherence and compliance in medicine – taking.2005. Report for the National Co‐ordinating Centre for NHS Service Delivery and Organisation R&D.

10.1111/j.1474-7766.2005.00313.x

10.18773/austprescr.2000.118

10.1111/j.2042-7174.2001.tb01032.x

10.1093/rheumatology/kei223

10.1046/j.1365-2710.2001.00363.x

Pitkin J, 2002, Compliance with estrogen replacement therapy: current issues, Climacteric, 5, 12

10.1093/jac/dkp049

10.7326/0003-4819-132-11-200006060-00026

10.1016/S0277-9536(97)00067-1

10.1016/0277-9536(88)90194-3

10.1002/14651858.CD003638.pub2

Sackett DL, 1976, Compliance with Therapeutic Regimens

Moulding T, 1961, Preliminary study of the pill calendar as a method of improving the self‐administration of drugs, Am Rev Respir Dis, 84, 284

10.1159/000288624

Blackwell B, 1998, Handbook of Psychosomatic Medicine, 625

10.2165/00128071-200607040-00004

10.1002/pds.1004

Urquhart J, 2005, New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics, Eur J Hosp Pharm Sci, 11, 103

10.1016/S0300-2977(96)80017-9

10.1111/j.1524-4733.2008.00464.x

10.1192/bjp.173.3.271c

Myers LB, 1998, Adherence to Treatment in Medical Conditions, 1

10.1177/002570879204900403

10.1002/dmrr.851

10.1345/aph.1D207

10.2307/3471947

10.1053/j.arrt.2004.01.003

10.1007/978-0-387-28370-8_44

10.2337/diacare.22.4.635

10.1258/136218000772085299

Royal Pharmaceutical Society of Great Britain, 1997, From Compliance to Concordance: Towards Shared Goals in Medicine Taking

10.1016/j.pec.2007.11.007

10.1136/jme.2005.012138

10.1136/bmj.319.7212.787

10.12968/jowc.2006.15.8.26947

Marinker M, 1998, The current status of compliance, Eur Respir Rev, 8, 235

10.1136/bmj.314.7082.691

10.1300/J010v42n03_09

10.1007/s10912-007-9030-4

10.1161/01.CIR.95.4.1085

10.1258/jhsrp.2008.008088

10.1111/j.1524-4733.2007.00304.x

10.1016/j.ijnurstu.2006.07.010

10.1016/j.mehy.2006.07.005

10.1016/j.pec.2005.09.014

10.1016/B978-012402771-8/50007-6

10.1057/palgrave.sth.8700028

10.2146/ajhp070372

10.1111/j.1600-0447.1999.tb10842.x

10.1046/j.1365-2702.2000.00309.x

Leventhal H, 1997, Treatment Compliance and the Therapeutic Alliance, 17

10.1097/00012272-199004000-00008

10.1176/appi.ap.29.2.203

Bond C, 2003, Concordance‐ Is it a synonym for compliance or a paradigm shift?, Pharm J, 271, 496

10.1046/j.1365-2850.2002.00474.x

10.12968/bjcn.2006.11.6.21221

10.1001/archinte.1990.00390190043003

10.1093/jpepsy/15.4.423

10.1016/0277-9536(85)90317-X

10.1111/j.1365-2125.2007.02893.x

10.1016/0277-9536(92)90206-6

10.1097/00004650-198902000-00011

Anthonisen NR, 2004, Persistence and compliance, Can Respir J, 11, 13, 10.1155/2004/763071

10.1016/j.amjhyper.2006.04.006

10.1097/01.JCN.0000287029.87746.58

10.1111/j.1399-5618.2005.00248.x

10.1111/j.1524-4733.2007.00213.x

10.1007/s11096-008-9196-5

10.1016/j.ahj.2006.10.018

10.1111/j.1524-4733.2007.00205.x

10.1080/J354v18n03_09

10.1586/14737167.4.3.317

10.1136/bmj.284.6308.24

10.1016/j.pec.2007.02.010

10.1007/s00198-008-0644-9

UrquhartJ VrijensB.Taxonomy of patient compliance‐related events in drug trials. Snowbird conference on causal inference 2001.2001.

10.1097/01.nmd.0000130132.55146.04

10.1016/S0025-6196(11)61093-8

10.1016/0197-2456(84)90012-6

10.1136/bmj.39553.670231.25

10.1111/j.1600-6143.2008.02495.x

10.2165/00003088-199427030-00004

10.1038/sj.clpt.6100499

10.1016/S0165-0327(96)00095-X

10.1111/j.1744-6198.1999.tb00230.x

10.1016/j.clinthera.2006.09.021

10.1016/S0168-8510(01)00178-6

10.1161/01.HYP.0000222373.59104.3d

10.1111/j.1524-4733.2006.00139.x

Sikka R, 2005, Estimating medication persistency using administrative claims data, Am J Manag Care, 11, 449

Haynes RB, 1979, Compliance in Health Care

10.1097/00006199-198201000-00007

Meichenbaum D, 1987, Facilitating Treatment Adherence: A Practioner's Guidebook, 10.1007/978-1-4684-5359-1

10.1097/01.mlr.0000166617.68751.5f